Navigation Links
Drug combination acts against aggressive chronic lymphocytic leukemia
Date:12/10/2012

increase in leukemia cells in the blood due to release of CLL cells from the tissues (lymph glands) into the blood stream. Rituximab, a well-established antibody, was added to capture the CLL cells in the blood and thereby accelerate and improve response.

"When we looked at how well the high-risk patients were doing on ibrutinib - even though it was a small number - we saw a great opportunity to find out if combining the two drugs would have a positive impact on these patients," Burger said.

Combination tolerated well

Forty patients with high-risk CLL were enrolled in the study earlier this year. They received:

  • Daily oral doses of 420 mg ibrutinib throughout treatment
  • Weekly infusions of rituximab (375 mg/m2) weeks one through four
  • Monthly rituximab infusions for the next five months

At a median follow up of four months, 38 patients remained on ibrutinib therapy without disease progression. One patient died from an unrelated infectious complication, and one patient discontinued therapy due to oral ulcers.

Preliminary results: 85 percent response rate

Of 20 patients evaluated for early response at three months, 17 achieved partial remission for an overall response rate of 85%. Three achieved partial remission with persistent lymphocytosis.

Interestingly, lymphocytosis peaked earlier and the duration was shorter than with ibrutinib alone.

Treatment was well tolerated, with 13 cases of grade 3 or grade 4 toxicities, including neutropenia, fatigue, pneumonia, insomnia and bone aches. Most side effects were unrelated and transient. Many patients reported improved overall health and quality of life after three cycles of treatment.

"Although this study has a short follow-up time, we are encouraged by the fact that the vast majority of patients are responding and are able to continue on treatment, Burger said.

Development of ibrutinib for CLL
'/>"/>

Contact: Scott Merville
smerville@mdanderson.org
713-516-4855
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. Scientists test 5,000 combinations of 100 existing cancer drugs to find more effective treatments
2. Combination treatment may improve survival of breast cancer patients with brain metastases
3. Drug combination against NRAS-mutant melanoma discovered
4. Combination peptide therapies might offer more effective, less toxic cancer treatment
5. DNDi and Cipla to develop 4-in-1 pediatric antiretroviral drug combination
6. BUSM in vitro study identifies potential combination therapy for breast cancer
7. Moffitt Cancer Center researchers test drug combinations to prevent graft vs. host disease
8. Discovery suggests new combination therapy strategy for basal-like breast cancers
9. Cancer vaccine combination therapy shows survival benefit in breast cancer
10. Combination of 2 drugs reverses liver tumors
11. Immunotherapy for elderly cancer patients finds new promise in drug combination
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drug combination acts against aggressive chronic lymphocytic leukemia
(Date:4/23/2014)... targets an important brain receptor has a dramatic effect ... behavior, a University at Buffalo animal study has found. ... be a novel lead compound for treating cocaine addiction, ... was published as an online preview article in ... compound, RO5263397, severely blunted a broad range of cocaine ...
(Date:4/23/2014)... science, "simple and accessible detection methods that can ... resolution of a single cell inside that population ... engineer Chang Lu. , In the Royal Society ... has announced that he and his coworkers have ... location of a protein ( Chem. Sci. , ...
(Date:4/23/2014)... - In a country as wealthy as the United States, ... seniors do not have access to adequate food due to ... insecure. , Recent research at the University of Illinois ... (NHANES) revealed that the seniors who are dealing with hunger ... "In 2011, 8.35 percent of Americans over age 60 faced ...
(Date:4/23/2014)... Effects of Midlife Occupational and Leisure Time Physical Activity ... physical activity in midlife increases the risk of mobility ... the risk. This is found in a study which ... The study was conducted at the Gerontology Research Center ... , Heavy physical labor is often repetitive, wears the ...
(Date:4/23/2014)... Getting to the bottom of Alzheimer,s disease has ... turns and controversies. In the latest crook in ... insight into the interaction between proteins associated with ... journal ACS Chemical Neuroscience , could have ... K. Surewicz, Krzysztof Nieznanski and colleagues explain that ...
Breaking Medicine News(10 mins):Health News:Novel compound halts cocaine addiction and relapse behaviors 2Health News:Following a protein's travel inside cells is key to improving patient monitoring, drug development 2Health News:More Americans in their golden years are going hungry 2Health News:Midlife occupational and leisure-time physical activity limits mobility in old age 2
... , NASHVILLE, Tenn., July 29 HCA Inc. ... 2009. , , (Logo: http://www.newscom.com/cgi-bin/prnh/20050825/CLTH069LOGO ... , Revenues increased 7.2 percent to $7.483 ... $282 million, compared to $141 million in the prior year,s second quarter. , ...
... ... first of its kind in the world , ... Clifton, NJ (PRWEB) July 28, 2009 -- Announcing the first HelpDesk for ... ,Proper clinical research is the only means to bring modern science and technology to diseased ...
... ... training program designed to help medical transcriptionists prepare to take the Registered Medical Transcriptionist ... ... leading online healthcare education company, has released a new online training program designed to ...
... ... the current economy: Vast amounts of vacancies and subleases are driving down initial rents ... ... International Tenant Representative Alliance , the current downturn in the economy provides a ...
... , , , ... more than 49,000 viewers, Family Research Council Action President Tony ... in five key states including Pennsylvania, Arkansas, Alaska, Louisiana, and Nebraska. ... Obama,s plan become reality - rationing and taxpayer funded abortions. ...
... , , EXTON, Pa., July 28 ... report assessing awareness of the Centers for Medicare and ... Medical Directors and Renal Administrators in dialysis units across ... affiliated with large dialysis chains (i.e. Fresenius, DaVita, DCI) ...
Cached Medicine News:Health News:HCA Reports Second Quarter 2009 Results 2Health News:HCA Reports Second Quarter 2009 Results 3Health News:HCA Reports Second Quarter 2009 Results 4Health News:HCA Reports Second Quarter 2009 Results 5Health News:HCA Reports Second Quarter 2009 Results 6Health News:HCA Reports Second Quarter 2009 Results 7Health News:HCA Reports Second Quarter 2009 Results 8Health News:HCA Reports Second Quarter 2009 Results 9Health News:HCA Reports Second Quarter 2009 Results 10Health News:HCA Reports Second Quarter 2009 Results 11Health News:HCA Reports Second Quarter 2009 Results 12Health News:HCA Reports Second Quarter 2009 Results 13Health News:HCA Reports Second Quarter 2009 Results 14Health News:Career Step Launches New Exam Prep Course for Medical Transcription Industry Credential 2Health News:This Summer is an Ideal Time for Commercial Real Estate Lease Renewal 2Health News:This Summer is an Ideal Time for Commercial Real Estate Lease Renewal 3Health News:FRC Action Launches TV Ad Campaign On Government Health Care Takeover 2Health News:New BioTrends Report Explores Anticipated Treatment Pattern Shifts Expected with the Proposed Bundled Payment Structure Planned for 2011 2
(Date:1/15/2014)... 2014  Zafgen, Inc., a leading biopharmaceutical company dedicated ... patients, today announced initial results from its Phase ... methionine aminopeptidase 2 (MetAP2), in patients with Prader-Willi ...  These results showed improvements in body weight, hunger-related ...
(Date:1/14/2014)...  Luminex Corporation (Nasdaq: LMNX ) today announced that ... 2013 on Monday, February 3, 2014. A press release announcing ... trading. (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ) ... highlights and financial results for the fourth quarter and twelve ...
(Date:1/14/2014)... Dynamic Healthcare Services, Inc. ("DHS"), a portfolio company of GMH ... Medical Equipment, Inc. ("Progressive") of Clarion, PA ... were not disclosed. Progressive is a full ... of sleep, mobility, and respiratory products to customers in the ...
Breaking Medicine Technology:Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 3
... ATLANTA, April 7, 2011 Vystar® Corporation ... Natural Rubber Latex (NRL), a patented, all-natural raw ... other non-rubbers found in natural rubber latex, has ... (Logo: http://photos.prnewswire.com/prnh/20100203/CL48049LOGO) Ms. Kearney ...
... Harriet Robinson, Ph.D., Chief Scientific Officer at GeoVax Labs, ... of the Company,s therapeutic and preventative HIV vaccines at the ... Convention Center in Washington DC on Thursday, April 14.  Dr. ... a.m., will cover the topic of recombinant viruses as vaccines. ...
Cached Medicine Technology:Vystar® Corporation Appoints Joanne Kearney as Vice President of Marketing 2Vystar® Corporation Appoints Joanne Kearney as Vice President of Marketing 3GeoVax Labs HIV/AIDS Vaccine Development Leadership to be Highlighted During 2011 World Vaccine Congress 2GeoVax Labs HIV/AIDS Vaccine Development Leadership to be Highlighted During 2011 World Vaccine Congress 3
Up-tapered output compresses NA to give low NA fiber performance on high NA fiber stock....
One piece, 100% fused silica construction offers low scatter and high efficiency...
... truly lateral, all quartz fiber. The design ... technology for Total Internal Reflection (TIR) at ... output is virtually indistinguishable from an axial ... in a round spot of low divergence. ...
The new series of Steris Power-lift Stirrups incorporate all of the proven clinical benefits of Allen-style booted stirrups: maximum safety for the patient, ease of setup for your staff, impressive v...
Medicine Products: